Compare · CHPT vs STE
CHPT vs STE
Side-by-side comparison of ChargePoint Holdings Inc. (CHPT) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHPT operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $23.05B, about 152.4x CHPT ($151.2M).
- STE has been more active in the news (16 items in the past 4 weeks vs 3 for CHPT).
- CHPT has more recent analyst coverage (25 ratings vs 17 for STE).
- Company
- ChargePoint Holdings Inc.
- STERIS plc (Ireland)
- Price
- $5.83-1.69%
- $236.43-0.47%
- Market cap
- $151.2M
- $23.05B
- 1M return
- -
- +8.14%
- 1Y return
- -
- -4.93%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 3
- 16
- Recent ratings
- 25
- 17
ChargePoint Holdings Inc.
ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest CHPT
- ChargePoint to Announce Second Quarter Fiscal Year 2027 Financial Results on September 2, 2026
- ChargePoint and Portland International Airport Set New Standard for Rental Car Electrification with Industry-Leading Overhead Fast Charging
- ChargePoint and Mercedes-Benz Partner to Simplify Fleet Electrification with End-to-End Charging Solutions
- ChargePoint Holdings Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure
- Director Singh-Bushell Ekta was granted 25,050 shares, increasing direct ownership by 122% to 45,627 units (SEC Form 4)
- Director Heystee Susan was granted 25,050 shares, increasing direct ownership by 120% to 45,945 units (SEC Form 4)
- Director Linse Michael was granted 27,555 shares, increasing direct ownership by 129% to 48,930 units (SEC Form 4)
- Director Leschly Mark was granted 26,386 shares, increasing direct ownership by 123% to 47,761 units (SEC Form 4)
- Director Harris Jeffrey was granted 28,390 shares, increasing direct ownership by 133% to 49,765 units (SEC Form 4)
- Director Harries Axel was granted 25,050 shares, increasing direct ownership by 117% to 46,425 units (SEC Form 4)
Latest STE
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward
- SEC Form 4 filed by Director Boulud Pierre
- SEC Form 4 filed by Director Feldmann Cynthia L
- SEC Form 4 filed by Director Holland Christopher S
- SEC Form 4 filed by Director Alegria Esther M.
- SEC Form 144 filed by STERIS plc (Ireland)